Cargando…
Ocular benzalkonium chloride exposure: problems and solutions
Preservatives in multidose formulations of topical ophthalmic medications are crucial for maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK)—used in approximately 70% of ophthalmic formulations—is well known to cause cytotoxic damage to conjunctival and corneal...
Autores principales: | Goldstein, Michael H., Silva, Fabiana Q., Blender, Nysha, Tran, Trung, Vantipalli, Srilatha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277985/ https://www.ncbi.nlm.nih.gov/pubmed/34262161 http://dx.doi.org/10.1038/s41433-021-01668-x |
Ejemplares similares
-
Ocular Toxicity of Benzalkonium Chloride Homologs Compared with Their Mixtures
por: Okahara, Akihiko, et al.
Publicado: (2013) -
Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
por: Walimbe, Tejaswini, et al.
Publicado: (2016) -
Aspergilli Response to Benzalkonium Chloride and Novel-Synthesized Fullerenol/Benzalkonium Chloride Nanocomposite
por: Unković, Nikola, et al.
Publicado: (2015) -
Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
por: Tokuda, Naoto, et al.
Publicado: (2017) -
Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease
por: Kim, Yeoun-Hee, et al.
Publicado: (2015)